Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations.

Hillary CuestaIbrahim El MenyawiAlphonse HubschLiane HoeffererOrell MielkeSusie GabrielAmgad Shebl

Published in: Transfusion (2022)

This analysis identified patient and product risk factors including blood group, IVIG dose, and IVIG manufacturing processes associated with elevated IVIG-related hemolysis incidence.

Keyphrases

risk factors
clinical trial
case report
randomized controlled trial
phase ii
double blind
genetic diversity
placebo controlled